|
Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$814
|
$766B |
13.0x |
30.3x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$187
|
$477B |
5.1x |
13.6x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$225
|
$462B |
7.7x |
18.0x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$87
|
$243B |
3.8x |
8.3x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$292
|
$205B |
5.8x |
11.3x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$24
|
$186B |
2.9x |
7.5x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$119
|
$167B |
5.8x |
11.1x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$43
|
$124B |
2.6x |
7.7x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$417
|
$102B |
8.6x |
22.1x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$144
|
$69.1B |
7.3x |
16.9x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$25.8B |
1.8x |
6.2x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$148
|
$25.5B |
2.6x |
7.9x |
|
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$37
|
$22.4B |
7.7x |
8.1x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$138
|
$13.1B |
4.7x |
19.5x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$6
|
$9.9B |
1.6x |
5.1x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$65
|
$8.6B |
6.8x |
10.5x |
|
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$5.8B |
1.9x |
8.6x |
|
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$52
|
$5.0B |
N/A |
N/A |
|
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$196
|
$4.6B |
2551.1x |
-16.5x |
|
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$31
|
$4.2B |
2.8x |
10.7x |
|
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$16
|
$3.7B |
7.5x |
16.9x |
|
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$3.6B |
5.6x |
16.1x |
|
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$3.5B |
N/A |
N/A |
|
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$36
|
$3.3B |
96.6x |
N/A |
|
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$98
|
$3.3B |
N/A |
N/A |
|
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$34
|
$3.2B |
34.4x |
-29.7x |
|
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$74
|
$3.1B |
N/A |
-19.9x |
|
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$25
|
$3.0B |
9.3x |
-71.1x |
|
Mineralys Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$40
|
$2.8B |
N/A |
-14.3x |
|
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$30
|
$2.8B |
7.1x |
-28.5x |
|
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$56
|
$2.6B |
3.8x |
19.5x |
|
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$29
|
$2.6B |
2466.2x |
-7.0x |
|
Disc Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$85
|
$2.6B |
N/A |
-12.7x |
|
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$68
|
$2.5B |
6.6x |
-33.8x |
|
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$92
|
$2.5B |
3.1x |
11.7x |
|
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$37
|
$2.5B |
3.9x |
31.0x |
|
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$16
|
$2.2B |
N/A |
-8.7x |
|
Avadel Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$19
|
$1.8B |
6.9x |
59.0x |
|
Xeris Biopharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$1.8B |
6.5x |
44.1x |
|
Collegium Pharmaceutical
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$35
|
$1.7B |
2.3x |
3.9x |
|
89bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$1.7B |
N/A |
-4.7x |
|
Spyre Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$24
|
$1.7B |
22872.8x |
-8.0x |
|
Amphastar Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$24
|
$1.6B |
2.1x |
5.9x |
|
Harrow
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$37
|
$1.5B |
5.7x |
22.8x |
|
Stoke Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$31
|
$1.5B |
9.2x |
-145.8x |
|
Sionna Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$37
|
$1.4B |
N/A |
-16.6x |
|
Sana Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$1.4B |
N/A |
-6.7x |
|
Aurinia Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$12
|
$1.4B |
5.2x |
N/A |
|
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$20
|
$1.4B |
5.6x |
-3.6x |
|
Maze Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Digital Therapeutics
|
$31
|
$1.3B |
44.4x |
-11.1x |
|
OPKO Health
|
United States of America |
Biopharmaceuticals,
Medical Imaging & Diagnostics
|
$1
|
$1.3B |
2.0x |
-9.7x |
|
Nuvation Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$1.3B |
44.2x |
N/A |
|
Zymeworks
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$19
|
$1.2B |
9.5x |
-23.9x |
|
Pharvaris
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$22
|
$1.2B |
N/A |
-6.4x |
|
Ardelyx
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$1.2B |
3.1x |
-75.6x |
|
WAVE Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$1.1B |
19.2x |
-6.4x |
|
Dianthus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$34
|
$1.1B |
363.9x |
N/A |
|
Innoviva
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$18
|
$1.1B |
2.8x |
N/A |
|
Zenas BioPharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$28
|
$1.0B |
29.0x |
-5.4x |
|
Phathom Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$14
|
$1.0B |
6.7x |
-6.1x |
|
Rapport Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$27
|
$1.0B |
N/A |
-8.4x |
|
Tourmaline Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$48
|
$994M |
N/A |
N/A |
|
ORIC Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$977M |
N/A |
-6.7x |
|
Oculis Holding
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$22
|
$927M |
940.9x |
-9.4x |
|
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$24
|
$912M |
375.1x |
-6.3x |
|
Emergent BioSolutions
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$902M |
1.1x |
4.7x |
|
Tango Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$887M |
15.7x |
N/A |
|
Esperion Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$3
|
$880M |
2.4x |
42.0x |
|
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$880M |
2.7x |
64.3x |
|
Enliven Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$23
|
$853M |
143846.8x |
-7.1x |
|
UroGen Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$20
|
$843M |
7.4x |
-7.3x |
|
Mind Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$842M |
N/A |
-5.9x |
|
Arbutus Biopharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$787M |
60.5x |
N/A |
|
Ironwood Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$2
|
$751M |
2.6x |
6.2x |
|
LENZ Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$31
|
$719M |
67.2x |
-9.7x |
|
Septerna
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Small Molecules
|
$22
|
$675M |
9.1x |
-8.3x |
|
Syndax
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$672M |
4.6x |
-2.4x |
|
Xencor
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$670M |
5.1x |
-3.7x |
|
MBX Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$20
|
$649M |
N/A |
-6.4x |
|
Relay Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$638M |
51.3x |
-2.0x |
|
Savara
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$4
|
$633M |
N/A |
N/A |
|
Elite Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1
|
$632M |
N/A |
N/A |
|
Anavex Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$587M |
32.0x |
N/A |
|
Astria Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$552M |
48.7x |
-3.7x |
|
Tyra Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$522M |
N/A |
-4.2x |
|
ArriVent BioPharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$19
|
$521M |
N/A |
-3.9x |
|
Akebia Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$2
|
$472M |
2.1x |
N/A |
|
Bicara Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$16
|
$433M |
N/A |
-3.2x |
|
Erasca
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$2
|
$415M |
N/A |
-2.8x |
|
Regenxbio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$403M |
2.0x |
-4.6x |
|
SIGA Technologies
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$402M |
3.6x |
8.4x |
|
Lexicon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$1
|
$401M |
10.5x |
-4.1x |
|
Terns Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$386M |
N/A |
-3.5x |
|
Armata Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$5
|
$337M |
62.0x |
-9.2x |
|
CytoDyn
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$0
|
$322M |
N/A |
N/A |
|
Nika Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$0
|
$308M |
N/A |
N/A |
|
Alpha Teknova
|
United States of America |
Contract Research & Manufacturing,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$5
|
$294M |
7.3x |
-32.2x |
|
Day One Biopharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$271M |
1.9x |
-1.7x |
|
4D Molecular Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$263M |
79.6x |
-1.2x |
|
Mereo BioPharma Group
|
United States of America |
Biopharmaceuticals
|
$2
|
$250M |
10.8x |
-103.2x |